Carl R. Iberger
2020
In 2020, Carl R. Iberger earned a total compensation of $431.9K as Chief Financial Officer at Transgenomic, a 77% increase compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $129,360 |
| Salary | $216,025 |
| Other | $11,551 |
| Total | $431,936 |
Iberger received $216K in salary, accounting for 50% of the total pay in 2020.
Iberger also received $75K in bonus, $129.4K in option awards and $11.6K in other compensation.
Rankings
In 2020, Carl R. Iberger's compensation ranked 11,397th out of 13,090 executives tracked by ExecPay. In other words, Iberger earned more than 12.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,397 out of 13,090 | 13th |
Division Manufacturing | 4,883 out of 5,618 | 13th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 661 out of 799 | 17th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 187 out of 227 | 18th |
Industry Laboratory Analytical Instruments | 70 out of 82 | 15th |
Source: SEC filing on April 28, 2022.
Iberger's colleagues
We found three more compensation records of executives who worked with Carl R. Iberger at Transgenomic in 2020.